CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 36 enrolled
Drug / intervention
MC2-01 Cream +6 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03758365
NCT03758365Phase 1Completed

A Randomized, Evaluator Blinded, Within Subject, Single-Centre Evaluation of the Vasoconstriction Properties of MC2-01 Cream, Compared to 5 Other Corticosteroids in Healthy Subjects

MC2 Therapeutics·interventional·Posted Nov 29, 2018·Updated Jan 9, 2020

In Brief

A Phase 1 clinical trial evaluating MC2-01 Cream, Clobetasol Propionate 0.05% Lotion, and 5 other interventions for Vasoconstriction. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The objective of this trial is to compare the vasoconstriction potential

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedNov 29, 2018
Enrollment StartNov 5, 2018
Primary CompletionNov 23, 2018
TodayJul 2, 2026
Enrollment to primary: 18 daysPosted 7.6 years ago

Interventions

MC2-01 Creamdrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Clobetasol Propionate 0.05% Lotiondrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Betamethasone Dipropionate 0.05% Creamdrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Triamcinolone Acetonide 0.1% Creamdrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Hydrocortisone Butyrate 0.1% Creamdrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Desonide 0.05% Creamdrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation

Vehicledrug

Single application, visual evaluation of skin blanching and local tolerability, physical examination and safety evaluation